This suggests that, in addition to mutp53 reduction, wtp53 reactivation contributed to the down-regulation of CHK1 and RAD51 observed in the HDACi-treated pancreatic cancer cells. This evidence concerns the gene CHEK1 and familial pancreatic carcinoma.